Low back pain affects an estimated one in four American adults and is the leading contributor to disability globally. In most ...
A new review of the evidence finds that only a handful of common remedies provide a modest benefit for acute or chronic back ...
In chronic low back pain, botulinum neurotoxin type A improved patients' pain and functional outcomes vs placebo and other local injection therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback